Vedran Katavić

2.0k total citations · 1 hit paper
48 papers, 1.5k citations indexed

About

Vedran Katavić is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Vedran Katavić has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 16 papers in Oncology and 9 papers in Immunology. Recurrent topics in Vedran Katavić's work include Bone Metabolism and Diseases (27 papers), Bone health and treatments (9 papers) and Inflammatory mediators and NSAID effects (6 papers). Vedran Katavić is often cited by papers focused on Bone Metabolism and Diseases (27 papers), Bone health and treatments (9 papers) and Inflammatory mediators and NSAID effects (6 papers). Vedran Katavić collaborates with scholars based in Croatia, United States and United Kingdom. Vedran Katavić's co-authors include Joseph Lorenzo, Héctor L. Aguila, Dora Višnjić, Žana Kalajzić, David W. Rowe, Ana Marušić, Danka Grčević, Nataša Kovačić, Ivan Krešimir Lukić and Matko Marušić and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Vedran Katavić

46 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematopoiesis is severely altered in mice with an induced osteoblast deficiency

2004 566 citations Vedran Katavić, Joseph Lorenzo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vedran Katavić Croatia	19	594	409	398	319	232	48	1.5k
Elizabeth A. Morgan United States	30	788 1.3×	535 1.3×	811 2.0×	404 1.3×	682 2.9×	93	2.5k
Amit Agarwal United States	18	372 0.6×	376 0.9×	360 0.9×	85 0.3×	76 0.3×	86	993
Peter Diamond Australia	20	616 1.0×	351 0.9×	409 1.0×	198 0.6×	123 0.5×	38	1.3k
Andrew Chantry United Kingdom	18	578 1.0×	603 1.5×	691 1.7×	86 0.3×	109 0.5×	60	1.3k
Lisa Murray Australia	11	731 1.2×	237 0.6×	376 0.9×	164 0.5×	172 0.7×	41	1.8k
Peter D. Emanuel United States	27	1.1k 1.8×	900 2.2×	294 0.7×	571 1.8×	578 2.5×	72	2.0k
Hélène A. Poirel Belgium	23	804 1.4×	778 1.9×	674 1.7×	351 1.1×	637 2.7×	56	2.1k
Carina Seidel Norway	20	903 1.5×	879 2.1×	682 1.7×	112 0.4×	115 0.5×	25	1.7k
Peter Duggan Canada	18	452 0.8×	841 2.1×	455 1.1×	168 0.5×	181 0.8×	106	1.4k
B. Guérette Canada	21	821 1.4×	341 0.8×	145 0.4×	409 1.3×	455 2.0×	60	1.8k

Countries citing papers authored by Vedran Katavić

Since Specialization

Citations

This map shows the geographic impact of Vedran Katavić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vedran Katavić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vedran Katavić more than expected).

Fields of papers citing papers by Vedran Katavić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vedran Katavić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vedran Katavić. The network helps show where Vedran Katavić may publish in the future.

Co-authorship network of co-authors of Vedran Katavić

This figure shows the co-authorship network connecting the top 25 collaborators of Vedran Katavić. A scholar is included among the top collaborators of Vedran Katavić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vedran Katavić. Vedran Katavić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Batorek‐Lukač, Nina, Tomislav Kelava, Igor Radanović, et al.. (2025). Midline 1 associated with Fas signaling enhances murine antigen-induced arthritis. Frontiers in Cell and Developmental Biology. 13. 1451093–1451093.

Kovačić, Nataša, et al.. (2022). In the eye of the beholder – how course delivery affects anatomy education. Annals of Anatomy - Anatomischer Anzeiger. 246. 152043–152043. 5 indexed citations

Batorek‐Lukač, Nina, et al.. (2020). RNA sequencing data from osteochondroprogenitor populations in synovial joints of mice during murine model of rheumatoid arthritis. SHILAP Revista de lepidopterología. 33. 106570–106570. 3 indexed citations

Silva, Jaime A. Teixeira da, Aceil Al‐Khatib, Vedran Katavić, & Helmar Bornemann‐Cimenti. (2017). Establishing Sensible and Practical Guidelines for Desk Rejections. Science and Engineering Ethics. 24(4). 1347–1365. 22 indexed citations

Jajić, Zrinka, Branimir Anić, Tomislav Kelava, et al.. (2017). Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells. Arthritis Research & Therapy. 19(1). 142–142. 61 indexed citations

Katavić, Vedran, et al.. (2014). Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis. International Orthopaedics. 38(9). 1893–1903. 43 indexed citations

Katavić, Vedran. (2014). Retractions of scientific publications: responsibility and accountability. Biochemia Medica. 24(2). 217–222. 17 indexed citations

Cvija, Hrvoje, Nataša Kovačić, Vedran Katavić, et al.. (2012). Chemotactic and Immunoregulatory Properties of Bone Cells are Modulated by Endotoxin-Stimulated Lymphocytes. Inflammation. 35(5). 1618–1631. 4 indexed citations

Kovačić, Nataša, Danka Grčević, Vedran Katavić, et al.. (2010). Fas receptor is required for estrogen deficiency-induced bone loss in mice. Laboratory Investigation. 90(3). 402–413. 29 indexed citations

10.

Kovačić, Nataša, Danka Grčević, Vedran Katavić, Ivan Krešimir Lukić, & Ana Marušić. (2010). Targeting Fas in osteoresorptive disorders. Expert Opinion on Therapeutic Targets. 14(10). 1121–1134. 16 indexed citations

11.

Grčević, Danka, et al.. (2008). Increased bone resorption and osteopenia are a part of the lymphoproliferative phenotype of mice with systemic over-expression of interleukin-7 gene driven by MHC class II promoter. Immunology Letters. 121(2). 134–139. 15 indexed citations

12.

Kovačić, Nataša, Ivan Krešimir Lukić, Danka Grčević, et al.. (2007). The Fas/Fas Ligand System Inhibits Differentiation of Murine Osteoblasts but Has a Limited Role in Osteoblast and Osteoclast Apoptosis. The Journal of Immunology. 178(6). 3379–3389. 48 indexed citations

13.

Chikazu, Daichi, Xiaodong Li, Hiroshi Kawaguchi, et al.. (2005). Bone Morphogenetic Protein 2 Induces Cyclo-oxygenase 2 in Osteoblasts via a Cbfa1 Binding Site: Role in Effects of Bone Morphogenetic Protein 2 In Vitro and In Vivo. Journal of Bone and Mineral Research. 20(10). 1887–1898. 9 indexed citations

14.

Katavić, Vedran, Ivan Krešimir Lukić, Nataša Kovačić, et al.. (2003). Increased Bone Mass Is a Part of the Generalized Lymphoproliferative Disorder Phenotype in the Mouse. The Journal of Immunology. 170(3). 1540–1547. 34 indexed citations

15.

Katavić, Vedran, Danka Grčević, Ivan Krešimir Lukić, et al.. (2003). Non-functional Fas ligand increases the formation of cartilage early in the endochondral bone induction by rhBMP-2. Life Sciences. 74(1). 13–28. 7 indexed citations

16.

Katavić, Vedran, Danka Grčević, Judith Kalinowski, et al.. (2003). The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone. 32(6). 581–590. 35 indexed citations

17.

Marušić, Ana, et al.. (2000). Role of B Lymphocytes in New Bone Formation. Laboratory Investigation. 80(11). 1761–1774. 40 indexed citations

18.

Marušić, Ana, Vedran Katavić, Danka Grčević, & Ivan Krešimir Lukić. (1999). Genetic variability of new bone induction in mice. Bone. 25(1). 25–32. 37 indexed citations

19.

Marušić, Ana, Danka Grčević, & Vedran Katavić. (1996). New Bone Induction by Bone Matrix and Recombinant Human Bone Morphogenic Protein -2 in the Mouse. Croatian Medical Journal. 37(4). 237–244. 6 indexed citations

20.

Marušić, Ana, Vedran Katavić, Davor Štimac, Vesna Kuŝec, & Stipan Jonjić. (1995). Bone Turnover in Homozygous β₂-Microglobulin Knock-Out Mice Does not Differ from That of Their Heterozygous Littermates. Clinical Chemistry and Laboratory Medicine (CCLM). 33(12). 915–918. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact